Skip to main content
Fig. 2 | BMC Health Services Research

Fig. 2

From: Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry

Fig. 2

Unadjusted treatment outcomes for the overall cohort and stratified per treatment regimen. # Fifteen patients discontinued treatment prematurely but achieved an SVR24; eleven patients treated with TPV/PR and four patients treated with BOC/PR. These patients were counted in both the discontinuation rate and the SVR rate

Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us